Gretchen Duhaime, Senior Financial Analyst at Leerink Swann & Co., said her Tufts education "certainly gets me in the door." This, she said, is partly due to the strong alumni presence at Tufts.

Award-winning restauranteur Chris Ponte confirmed that he is expanding his Tampa restaurants, On Swann and Olivia, to Sarasota, his largest and furthest expansion to date of his many local spots.

The latest from French writer-director Vladimir de Fontenay tracks a father (Swann Arlaud) and son stranded together in the Nordic wilderness. By Jordan Mintzer Movies about irresponsible ...

Leerink analyst Joseph Schwartz notes Outperform-rated Sarepta (SRPT) disclosed two-year Part 1 and one-year Part 2 data from the EMBARK study with Elevidys. The firm views these topline results ...

Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for Beam Therapeutics’ current full-year earnings is ($4.64) per share.

Don Swann was an important American printmaker. Known for his detailed depictions of colonial and Neo-classical American architecture, his artworks serve as both important historical documents and ...

Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $0.11 for the quarter, up from their previous forecast of $0.02.

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a price target of $18.00. The company’s shares ...

On Friday, Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical ...

On Monday, Progyny (NASDAQ:PGNY) shares saw a change in their market prospects as Leerink Partners adjusted the company's price target. Analysts at Leerink Partners increased the price target on ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street's Radar. In this article, we are going to take a look at where Certara Inc. (NASDAQ:CERT) stands against the other ...

On Friday, Leerink Partners maintained a positive outlook on shares of Eli Lilly and Company (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $950.00. The pharmaceutical giant ...